| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCJ-037 | 10-Gingerol | >98%,Standard References |
|
| DCC-052 | Atractyloside A | >98%,Standard References |
|
| DCS-041 | Sudan III；Solvent Red 23 | >98%,Standard References |
|
| DCY-165 | Ethoxysanguinarine | >98%,Standard References |
|
| DCB-022 | (-)-Epicatechin gallate | >98%,Standard References |
|
| DCM-059 | (-)-Gallocatechin gallate | >98%,Standard References |
|
| DCB-023 | (-)-Epigallocatechin gallate | >98%,Standard References |
|
| DCJ-005 | Cichoric acid | >98%,Standard References |
|
| DCZ-143 | 7-Ethylcamptothecin | >98%,Standard References |
|
| DCS-016 | 7-Ethyl-10-Hydroxy-Camptothecin | >98%,Standard References |
|
| DCQ-046 | Oroxyloside | >98%,Standard References |
|
| DCS-061 | Trifolirhizin | >98%,Standard References |
|
| DCH-017 | Glycitin | >98%,Standard References |
|
| DCM-020 | Calycosin-7-O-beta-D-glucoside | >98%,Standard References |
|
| DCJ-017 | 3’- Methoxy Puerarin | >98%,Standard References |
|
| DCX-033 | Diosmetin-7-O-β-D-glucopyranoside | >98%,Standard References |
|
| DCS-026 | Tectoridin | >98%,Standard References |
|
| DCY-137 | Isorhamnetin-3-O-galactoside | >98%,Standard References |
|
| DCY-080 | Isorhamnetin-3-O-β-D-Glucoside | >98%,Standard References |
|
| DCB-044 | Praeruptorin C | >98%,Standard References |
|
| DCG-007 | Podophyllotoxin | >98%,Standard References |
|
| DCM-013 | Ononin | >98%,Standard References |
|
| DCJ-049 | 4'-O-Methylpuerarin | >98%,Standard References |
|
| DCT-033 | Dehydrocorydaline | >98%,Standard References |
|
| DCW-009 | Schisandrin C | >98%,Standard References |
|
| DCQ-083 | 3,5,6,7,8,3’,4’-heptemthoxyflavone | 3,5,6,7,8,3',4'-Heptemthoxyflavone, a flavonoid from satsuma peel, is an orally available CREB activator with anti-tumor and anti-neuroinflammatory activity. 3,5,6,7,8,3',4'-Heptemthoxyflavone inhibits collagenase activity and increases the content of type I procollagen in human dermal fibroblast neoblast (HDFn) cells. 3,5,6,7,8,3',4'-Heptemthoxyflavone induces brain-derived neurotrophic factor (BDNF) expression through the cAMP/ERK/CREB signaling pathway and reduces phosphodiesterase activity in C6 glioma. |
|
| DCY-010 | Isocorynoxeine | >98%,Standard References |
|
| DCQ-081 | Corynoxeine | >98%,Standard References |
|
| DCM-041 | Agnuside | >98%,Standard References |
|
| DCX-023 | Curculigoside | >98%,Standard References |
|
